<DOC>
	<DOCNO>NCT01314664</DOCNO>
	<brief_summary>The purpose study observe describe effectiveness local tolerability intravesical treatment valrubicin non-muscle invasive bladder cancer ( NMIBC ) cohort subject treat routine practice condition .</brief_summary>
	<brief_title>A Prospective Registry Assess Effectiveness Local Tolerability Intravesical Valrubicin Subjects With Non-muscle Invasive Bladder Cancer ( NMIBC )</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Valrubicin</mesh_term>
	<criteria>Males females 18 year age old Diagnosed NMIBC Prescribed intravesical valrubicin treat NMIBC Understood sign Informed Consent participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Non-Muscle Invasive Bladder Cancer</keyword>
	<keyword>CIS</keyword>
	<keyword>BCG Refractory</keyword>
</DOC>